Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Software Platform Extends MS Analysis to Include Small Molecules

By HospiMedica staff writers
Posted on 05 Jun 2008
A new software platform has extended its mass spectrometry (MS) franchise to include small molecules in addition to protein analysis.

Although MS manufacturers are selling an increasing number of instruments for small molecule analysis, the bioinformatics aspect has been mostly underdeveloped. More...
The new software program, SmileMS, offers robust, machine-independent software for the analysis of MS spectra from small molecules; a modern and dynamic user interface enabling users to seamlessly navigate through and share their results; and an open database of small molecule spectra allowing users to add both public and private data, enrich their proper search domain, and more share the database with other users.

SmileMS is a unique software platform for the identification and analysis of small molecules by liquid chromatography-mass spectrometry techniques. Developed by Geneva Bioinformatics (GeneBio; Geneva, Switzerland), in collaboration with the Swiss Institute of Bioinformatics (SIB; Geneva, Switzerland) and Prof. Denis Hochstrasser's group at Geneva University Hospitals (Geneva, Switzerland), SmileMS targets a growing need a growing need for efficient and automatable processes for routine daily analysis of small molecules.

Prof. Denis Hochstrasser said, "My lab has been thoroughly working with the GeneBio team for more than a year now and we are very happy with the quality of the results SmileMS is producing in its early version. The tool by far surpasses other tools we have tested for both the quality of its results, its user-friendliness, and most importantly its extreme flexibility; using the same tool and databases with different separation methods and instruments as well as sharing the results amongst different users through Web access show great promise for routine clinical application.”


Related Links:
Geneva University Hospitals
Geneva Bioinformatics
Swiss Institute of Bioinformatics

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Portable Electronic Pipette
Mini 96
New
Hemodynamic System Monitor
OptoMonitor
New
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Dormant tumor cells evade imaging tests and may later reactivate to spread metastatic breast cancer (Photo courtesy of David A. Litman/Shutterstock)

MRD Testing Can Identify Breast Cancer Survivors at Higher Risk of Recurrence

Breast cancer survival rates continue to improve, but recurrence remains incurable and affects around 30% of patients. Some subtypes, like triple negative and HER2+, relapse within years, while ER+ cancers... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.